Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
250.00    0.00 (0.00%)
Bid:
245.00
Ask:
255.00
Spread: 10.00 (4.082%)
Market Cap: £227.11m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Product Launch

1 Mar 2013 14:15

RNS Number : 0552Z
Concurrent Technologies PLC
01 March 2013
 



01 March 2013

Concurrent Technologies Plc

 

Product Launch

Optimised solutions now available for users of MicroTCA® systems

with Serial Rapid IO® fabric

 

Concurrent Technologies Plc (the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products for critical applications in the defence, aerospace, telecommunications, transportation, scientific and industrial markets, is pleased to announce the launch of its latest high performance MicroTCA® processor board, the AM 94x/x1x, with support for FIN-S across the Serial RapidIO® networked backplane.

 

This combination of the Company's hardware and software products has demonstrably shown a high bandwidth and low latency solution which utilizes about 5% of the CPU's bandwidth and provides an excellent opportunity for PowerPC® users who use Serial RapidIO® backplane networking to advance to Intel® Core™ i7 processor technology. This hardware and software combination is suitable for applications where a large number of computing nodes are required to intercommunicate at high data rates and with minimum latency.

 

Glen Fawcett, Managing Director, Concurrent Technologies Plc, commented:

 

"Users can take advantage of the boards' processing power, high performance backplane fabric connectivity and the peer-to-peer networking performance of Serial RapidIO® to develop large multiprocessing systems. This enhanced solution is particularly well suited to telecommunications applications such as IPTV, digital media servers, media gateways, broadband, Long Term Evolution (LTE) or LTE-Advanced, wireless base stations as well as in test systems for wireline and wireless networks."

 

Enquiries:

Concurrent Technologies PlcGlen Fawcett, Managing Director

 

+44 (0)1206 752 626

Newgate Threadneedle (Financial PR)Caroline Evans-Jones

Robyn McConnachie

+44 (0)207 653 9850

Cenkos Securities plc (NOMAD)Ken FlemingNeil McDonald

+44 (0)131 220 6939+44 (0)131 220 9771

 

Note to Editors:

 

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using Intel® processors, including the latest 3rd generation Intel® Core™ i7, 2nd generation Intel® Core™ i7, Intel® Core™ i7 processors, Intel® Xeon® and Atom™ processors, the Company offers a wide range of computer products which are designed to be compliant with industry specifications including those for products used in extremely harsh environments.

 

About Serial RapidIO®

This is a high-performance packet-switched architecture for interconnecting boards to each other using a backplane. This technology is designed specifically for embedded systems, primarily for the signal processing, networking, and communications markets.

 

For more information on Concurrent Technologies Plc and its products please visit www.cct.co.uk

 

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLJBMITMBBMBBJ
Date   Source Headline
22nd May 20183:41 pmRNSAGM Statement
21st May 20187:00 amRNSProduct Announcement
30th Apr 20189:30 amRNSDistribution of Annual Report and Accounts
4th Apr 20187:00 amRNSResults for the year ended 31 December 2017
3rd Apr 20189:01 amRNSProduct Announcement
28th Mar 20184:03 pmRNSNotice of Results
27th Mar 20182:14 pmRNSProduct Announcement
8th Mar 20187:00 amRNSSecond Interim Dividend
26th Feb 201810:17 amRNSCorrection - Product Announcement
26th Feb 20187:00 amRNSProduct Announcement
21st Feb 20187:00 amRNSProduct Announcement
23rd Jan 20187:00 amRNSProduct Announcement
21st Dec 20177:00 amRNSPre-Close Trading Update
30th Nov 20171:29 pmRNSProduct Announcement
18th Sep 20177:00 amRNSInterim Results for the six months ended 30 Jun 17
5th Sep 20177:00 amRNSNotice of Results
26th Jun 20177:00 amRNSProduct Announcement
25th May 20172:57 pmRNSResult of AGM
9th May 20177:00 amRNSNotice of AGM
12th Apr 20172:08 pmRNSDistribution of Annual Report and Accounts
30th Mar 201711:18 amRNSHolding(s) in Company
29th Mar 20174:33 pmRNSHolding(s) in Company
24th Mar 20177:00 amRNSFinal Results
22nd Mar 20177:00 amRNSNotice of Results
2nd Mar 201710:11 amRNSProduct Announcement
24th Feb 20177:00 amRNSSecond Interim Dividend
30th Jan 20179:23 amRNSProduct Announcement
13th Jan 20179:30 amRNSHolding(s) in Company
13th Jan 20179:30 amRNSHolding(s) in Company
20th Dec 20162:36 pmRNSPre-Close Trading Update
16th Dec 20163:13 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSProduct Launch
29th Sep 20167:00 amRNSProduct Launch
22nd Sep 20162:45 pmRNSTotal Voting Rights
9th Sep 201612:05 pmRNSDirector/PDMR Shareholding
30th Aug 20165:05 pmRNSHolding(s) in Company
30th Aug 201612:59 pmRNSHolding(s) in Company
26th Aug 20167:00 amRNSInterim Results
19th Aug 20162:21 pmRNSNotice of Interim Results
22nd Jul 20161:55 pmRNSHolding(s) in Company
1st Jul 20167:00 amRNSTrading Update
1st Jun 20162:43 pmRNSTotal Voting Rights
19th May 201612:56 pmRNSAGM Statement
12th May 20165:18 pmRNSDirector/PDMR Shareholding
6th May 20167:00 amRNSProduct Launch
19th Apr 20163:51 pmRNSDirector/PDMR Shareholding
19th Apr 201612:10 pmRNSDirector/PDMR Shareholding
18th Apr 20162:14 pmRNSDirector/PDMR Shareholding
18th Apr 201610:55 amRNSPosting of Annual Report & Accounts
29th Mar 20164:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.